№ files_lp_4_process_1_28109
File format: docx
Character count: 6846
File size: 61 KB
The document provides supplementary material for a study on CYP3A4 coding variants in breast and ovarian cancer patients treated with paclitaxel, presenting patient characteristics and genetic data related to neuropathy risk.
Year:
2023
Region / City:
Unknown
Topic:
Cancer Research, Pharmacogenetics
Document Type:
Research Supplementary Material
Organization / Institution:
Unknown
Author:
Unknown
Target Audience:
Researchers, Medical Professionals
Period of Validity:
Ongoing
Approval Date:
Unknown
Modification Date:
Unknown
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Subject:
Veterinary diagnostics
Document type:
Research/Diagnostic guideline
Organization:
Cornell Animal Health Diagnostic Center
Target audience:
Veterinarians
Year:
2026
Event:
Canadian Conference on Ovarian Cancer Research
Location:
Vancouver, BC, Canada
Prize amount:
$5,000 CAD
Eligibility:
Trainees at any level conducting ovarian cancer research
Submission period:
January 1, 2024 – December 31, 2025
Application deadline:
February 20, 2026
Notification date:
April 1, 2026
Award components:
Presentation at Anita Unruh Award Lecture, registration and travel coverage
Organizers:
Ovarian Cancer Canada
Selection criteria:
Scientific merit, relevance, innovation
Type:
Award announcement and application guidelines
Target audience:
Trainees in biomedical and clinical research
Authors:
Joseph Westaby; Nesreen Magdy; Cyril Fisher; Mona El-Bahrawy
Institutions:
Department of Histopathology, Imperial College London, UK; Department of Histopathology, National Cancer Institute, Egypt; Sarcoma Unit, The Royal Marsden Hospital, UK; Faculty of Medicine, Alexandria University, Egypt
Corresponding author:
Dr Mona El-Bahrawy
Journal type:
Medical case report
Field:
Histopathology; Oncology; Gynaecological pathology
Keywords:
Perivascular Epithelioid Cell Neoplasms; PEComas; ovary; malignant; primary
Patient age:
54 years
Diagnosis:
Malignant primary ovarian PEComa
Clinical outcome:
Recurrence and death five months after surgery
Language:
English
Year:
2021
Region / City:
Global
Topic:
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Histopathology
Document Type:
Reporting Guide
Organization / Institution:
International Collaboration on Cancer Reporting (ICCR)
Author:
Merlin T, Weston A, Tooher R
Target Audience:
Pathologists, Oncologists, Medical Researchers
Effective Period:
2021 onwards
Approval Date:
2021
Date of Changes:
June 2021
Year of diagnosis:
2021
Place of residence:
Belfast
Medical condition:
Stage 4b high-grade serous ovarian cancer
Type of document:
Personal testimony
Healthcare context:
Emergency gynaecology admission and oncology treatment
Support services mentioned:
Palliative care, Macmillan nurse, clinical nurse specialist
Initiative referenced:
Cancer Survivorship initiative
Key component described:
Holistic Needs Assessment (HNA)
Treatment received:
Chemotherapy
Prognosis update:
Terminal diagnosis in July 2023 with less than 12 months prognosis
Themes:
Palliative care, holistic support, survivorship, quality of life, patient experience
Year:
2023
Region / City:
United Kingdom
Topic:
Ovarian Tumours in Children
Document Type:
Survey Report
Organization / Institution:
British Association of Paediatric Surgeons (BAPS), Children’s Cancer and Leukaemia Group (CCLG)
Author:
Not specified
Target Audience:
Paediatric Surgeons, Paediatric Oncology Specialists
Period of Validity:
Not specified
Date of Approval:
Not specified
Date of Changes:
Not specified
Contextual Description:
A national survey report detailing varying approaches among paediatric surgeons in the UK regarding the management of ovarian tumours in prepubertal children, focusing on diagnostic procedures, surgery, and follow-up practices.
Year:
2026
Region:
Not specified
Subject:
Gene expression analysis in ovarian cancer
Document type:
Supplementary table
Institution:
Not specified
Authors:
Not specified
Target audience:
Researchers in oncology and genomics
Data type:
Upregulated and downregulated DEGs
Sample type:
Normal and early ovarian cancer tissue samples
Analysis method:
Differential gene expression profiling
Number of genes listed:
Extensive gene list with DEGs
Year:
2019
Region / City:
Australia and New Zealand
Subject:
Ovarian cancer clinical trials
Document type:
Call for research proposals
Organization:
ANZGOG (Australian and New Zealand Gynaecological Oncology Group)
Target audience:
Researchers in ovarian cancer
Funding:
Up to $500,000 per trial, Phase II only
Application period:
8 July 2019 – 4 October 2019
Study phase:
Phase Ib / II signal-seeking trials
Requirements:
Collaborative development, scientific rationale, translational component, potential for Phase III expansion
Submission process:
Administrative review, scientific review, funding review, board ratification, final notification
Year:
2026
Region / city:
Istanbul, Turkey
Topic:
Histology, Endocrinology, Ovarian Transplantation
Document type:
Research Article
Author:
Ph.D. Ali DOĞAN, Assoc. Prof. Dr. Ayşe YAZAR
Target audience:
Scientists, Medical Researchers, Healthcare Professionals
Period of validity:
N/A
Approval date:
N/A
Date of last revision:
N/A
Year:
2026
Field:
Cancer research, spatial transcriptomics
Document type:
Supplementary data / Methods
Authors:
Sammy Ferri-Borgogno, Ying Zhu, Jianting Sheng, Jared K. Burks, Javier Gomez, Kwong Kwok Wong, Stephen T.C. Wong, Samuel C. Mok
Institution:
Unspecified (data from GEO database and previous publications)
Sample:
High-grade serous ovarian cancer patients
Techniques:
scRNA-seq, spatial transcriptomics, UMAP, PCA, GO enrichment analysis
Data source:
GEO database
Cell types analyzed:
Epithelial cells, fibroblasts, endothelial cells, T cells, B cells, myeloid cells, NK cells, dendritic cells, monocytes, macrophages
Analysis period:
Not specified
Methodology details:
Differential expression analysis, cluster annotation, ligand-receptor interaction assessment
Year:
2026
Region / City:
Shanghai, China
Topic:
Cancer immunotherapy, ovarian cancer
Document Type:
Research article with supplementary materials
Institution:
Fudan University, Obstetrics and Gynecology Hospital; Shanghai Cancer Center
Authors:
Kankan Cao, Guodong Zhang, Moran Yang, Yiying Wang, Mengdi He, Chen Zhang, Yan Huang, Jiaqi Lu, Haiou Liu
Target Audience:
Biomedical researchers, oncologists
Experimental Models:
Mouse xenografts and isografts (OVCAR-5, SKOV3, HM1, ID8agg)
Methodologies:
RNA sequencing, CCK-8 proliferation assay, BrdU incorporation, colony formation assay, migration assay, Random Forest analysis, scRNA-seq
Therapeutic Interventions:
St3gal3 inhibition, macrophage depletion, CXCR3 blocking, α2,3 sialylation targeting, dual immune checkpoint blockade (anti-PD-1, anti-CTLA-4)
Data Repositories:
GEO accession numbers GSE213219, GSE224856, GSE158937, GSE147082
Supplementary Materials:
Figures S1–S14, detailed methods, references
Year:
TBC
Region / City:
TBC
Subject:
Medical treatment, Cancer research
Document Type:
Advisory Interests Register
Organization / Institution:
NICE
Author:
Multiple
Target Audience:
NICE Committee members, medical experts
Period of Validity:
Until 02/12/2025
Approval Date:
TBC
Date of Changes:
TBC
Jurisdiction:
Victoria, Australia
Subject area:
Assisted reproductive treatment and gamete or embryo storage
Document type:
Administrative application form
Responsible body:
Patient Review Panel
Related legislation:
Assisted Reproductive Treatment Act 2008
Associated authorities:
Department of Health Victoria
Applicable materials:
Embryos; sperm; eggs; ovarian tissue
Applicants:
Sperm providers, egg providers, recipients of donated reproductive material, or other authorised applicants
Institutions referenced:
Fertility clinics and assisted reproductive treatment providers
Submission method:
Email submission to Patient Review Panel and notification to treating clinic
Decision output:
Certificate of decision issued by the Panel
Personal data involved:
Personal identification information and health-related information
Legal and privacy framework:
Privacy and Data Protection Act 2014; Health Records Act 2001
Geographical scope:
State of Victoria, Australia